Rapt Therapeutics, INC DEF 14A proxy statements
Proxy statements, covering the matters put to shareholders at the annual meeting — board elections, auditor ratification and executive pay.
RAPT Therapeutics will hold its annual meeting on May 29, 2025, with proposals including the election of a director, ratification of the auditor, executive compensation, and a potential reverse stock split.
RAPT Therapeutics is asking stockholders to approve a reverse stock split, a new equity incentive plan, and an amendment to its employee stock purchase plan at the upcoming annual meeting.
DEFA14A: RAPT Therapeutics Sets Date for 2024 Annual Meeting, Outlines Proposals for Stockholder Vote
RAPT Therapeutics, Inc. announces its 2024 Annual Meeting and provides details on proposals for stockholder voting, including the election of directors and ratification of the company's independent auditor.
RAPT Therapeutics is holding its annual stockholder meeting on May 22, 2024, to elect directors and ratify the appointment of its independent auditor.